Humacyte HUMA
NASDAQ HUMA
$0.41 +0.01 (+1.28%)
At close: Oct 21, 2026 · 4:00 PM EDT

Humacyte (HUMA) Short term Debt (2020 - 2025)

Updated

Humacyte (HUMA) recorded Short term Debt of $3.07 million in Q3 2025, up 45.2% from the prior quarter.

Analysis

Humacyte (HUMA) Short term Debt (2020 - 2025) Analysis & Trends

At the end of FY2024, Humacyte reported Short term Debt of $885,000.

  • Annual Short term Debt has a four-year compound annual growth rate of -22.5% (FY2020 to FY2024).
  • Across earlier years, Short term Debt came in at $8.57 million in FY2022 and $2.45 million in FY2020.
  • The Q3 2025 figure is the highest quarterly Short term Debt since Q1 2023.
  • Per Business Quant, the preceding three quarters came in at $2.12 million (Q2 2025), $1.69 million (Q1 2025) and $885,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Humacyte 97.33 Mn -101.11 Mn -825,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.07 Mn
Jun 30, 2025 2.12 Mn
Mar 31, 2025 1.69 Mn
Dec 31, 2024 885,000.00
Mar 31, 2023 12.86 Mn
Dec 31, 2022 8.57 Mn
Sep 30, 2022 4.29 Mn
Sep 30, 2021 3.89 Mn
Dec 31, 2020 2.45 Mn
API Access

Humacyte Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=HUMA&period=max&api_key=YOUR_API_KEY